Last edited by Tazil
Sunday, April 19, 2020 | History

3 edition of SEER, Surveillance, Epidemiology, and End Results Program found in the catalog.

SEER, Surveillance, Epidemiology, and End Results Program

SEER, Surveillance, Epidemiology, and End Results Program

  • 252 Want to read
  • 5 Currently reading

Published by National Institutes of Health, National Cancer Institute in [Bethesda, Md.] .
Written in English

    Subjects:
  • SEER Program (National Cancer Institute (U.S.)),
  • Cancer -- Reporting -- United States,
  • Cancer -- Research -- United States

  • Edition Notes

    SeriesNIH publication -- no. 00-4772
    ContributionsSEER Program (National Cancer Institute (U.S.)), National Cancer Institute (U.S.)
    The Physical Object
    Pagination8 p. :
    ID Numbers
    Open LibraryOL14512438M
    OCLC/WorldCa44940487

    @article{osti_, title = {Management of Male Breast Cancer in the United States: A Surveillance, Epidemiology and End Results Analysis}, author = {Fields, Emma C., E-mail: @ and DeWitt, Peter and Fisher, Christine M. and Rabinovitch, Rachel}, abstractNote = {Purpose: To analyze the stage-specific management of male breast cancer (MBC) . Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program Paras P. Vakharia, Ryan C. Kelm, Kelsey A. Orrell, Kevin R. Patel, Vivek Singam, Yasmeen Ali, Supriya Rastogi, Rame Yousif, Stephanie M. Rangel, Dennis P. West. PURPOSE Despite being the most common pediatric solid tumors, incidence and outcome of CNS tumors in Chinese children have not been systematically reported. We addressed this knowledge gap by comparing the epidemiology of pediatric CNS tumors in Hong Kong and the United States. PATIENTS AND METHODS Data between and from a population-based cancer registry in Hong . 2 days ago  (1) Surveillance, Epidemiology, and End Results Program (SEER), In terms of survival, late detection ultimately attests to the loss of life associated with occupational carcinogenic.

    Background: Primary signet-ring cell carcinoma (SRCC) is a rare variation of adenocarcinoma. Although SRCC of the urinary bladder is highly malignant, it is often neglected due to its als and Methods: We used the national Surveillance, Epidemiology, and End Results (SEER) database (–) to compare SRCC with urothelial carcinoma (UC) and investigated the prognostic values.


Share this book
You might also like
An historical sketch of the First Church in Boston

An historical sketch of the First Church in Boston

Morris and matachin

Morris and matachin

Russian culture, an outline

Russian culture, an outline

arts and crafts movement in the Cotswolds

arts and crafts movement in the Cotswolds

The innocents abroad

The innocents abroad

Recent economic growth in northeast England

Recent economic growth in northeast England

Sills.

Sills.

The faith of Robert Louis Stevenson

The faith of Robert Louis Stevenson

Backlash.

Backlash.

Cassells English-Dutch, Dutch-English dictionary

Cassells English-Dutch, Dutch-English dictionary

Terra Christa

Terra Christa

Prospects for commercial property in the 1990s

Prospects for commercial property in the 1990s

Mains patent economic printing press.

Mains patent economic printing press.

Perception and deception

Perception and deception

This business of living

This business of living

SEER, Surveillance, Epidemiology, and End Results Program Download PDF EPUB FB2

The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population. SEER is supported by SEER Surveillance Research Program (SRP) in NCI's Division of.

This mandate led to the establishment of the National Cancer Institute’s (NCI’s) Surveillance, Epidemiology, and End Results (SEER) Program. external icon 1.

The SEER Program continues to— Monitor the burden of cancer in the United SEER. Provide statistics on cancer incidence, survival, and mortality in the United States. SEER (Surveillance, Epidemiology, and End Results Program) Source: Surveillance and Operations Research Branch, Blair Building, RoomNational Cancer Institute (NCI), National Institutes of Health, Bethesda, MDCited by:   The Surveillance, Epidemiology and End Results (SEER) database was and End Results Program book for patients diagnosed with Wilms' tumor between and Patients were stratified into pediatric (Cited by:   The authors Surveillance the incidence, sociodemographics, prognostic variables, and treatment trends of this cancer in the Surveillance, Epidemiology, and End Results (SEER) limited database (‐).

The SEER‐Medicare database (‐) was used to estimate chemotherapy use. RESULTS: There were patients in the SEER limited by: SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS).

SRP provides national leadership in the science of cancer Epidemiology as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable population-based. SEER is supported by the Surveillance Research Program (SRP) and End Results Program book NCI's Division of Cancer Control and Population Sciences SEER provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable population-based statistics.

SEER's Training Website was developed to provide web-based training modules for cancer registration and surveillance, but can be used by anyone. The training and End Results Program book on this site are funded by the U.S.

National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program. Guidelines, Surveillance, and resources for cancer registrars, including coding and staging manuals, glossary, drug database (SEER*Rx), SEER abstracting tool (SEER*Abs), Q&A resources, and training modules for registration and surveillance.

Also read SEER announcements or join e-mail list. This Epidemiology compares clinical features and outcomes of SS across the different age groups, by analyzing cases, children/adolescents (≤18 years) and adults, registered in the Surveillance, Epidemiology, and End Results (SEER) 17 database from to Cited by: The SEER, Epidemiology and End Results (SEER) Program Two National Cancer Institute (NCI) programs, the End Results program Surveillance the Third National Cancer Survey, preceded SEER.

The SEER Program was established under the National Cancer Program by the National Cancer Act of ; data collection began in January   Surveillance, Epidemiology, and End Results (SEER) Program The NCI-funded SEER Program was established in Epidemiology is a population-based surveillance system that collects data from various cancer registries.

NCI's Surveillance, Epidemiology, and End And End Results Program book (SEER) program provides information on cancer statistics that underpins efforts Epidemiology reduce the cancer burden among the U.S.

population. Learn more about the SEER program. Surveillance METHODS: The Surveillance, Epidemiology and End And End Results Program book (SEER) database was analyzed for patients diagnosed with Wilms’ tumor between and Patients were stratified into pediatric (RESULTS: A total of patients ( pediatric and adult)Cited by: National Cancer Institute () Surveillance, Epidemiology and End Results Program (SEER) Cancer Statistics Review, National Cancer Institute, Besthesda.

has been cited by the following article: And End Results Program book Impact of Thyroglobulin on Survival and. Analysis of the surveillance, epidemiology, and end results (SEER) program registry in the United States from an 8-year period during the s identified an incidence rate of carcinoids of the lung and bronchus at persimilar to the rate in the small intestine.

40 A subsequent study has shown a consistent increase in incidence, with perhaving been reached in 41,42 It. Here, we present characteristics of patients diagnosed with astroblastomas using the Surveillance, Epidemiology, and End Results (SEER) database.

Methods. The SEER program, created by the National Cancer Institute (NCI), includes population-based cancer registries from 20 selected geographic areas in the United States, covering approximately 28% of the U.S. population, and the registries participating in the SEER program capture Cited by: Additional Physical Format: Online version: SEER, Surveillance, Epidemiology, and End Results Program.

[Bethesda, Md.]: National Institutes of Health, National. Methods: Patients diagnosed with carcinosarcoma of the prostate from through were identified in the Surveillance, Epidemiology, and End Results (SEER) database.

Outcomes were examined with Kaplan-Meier survival analysis and Cox models. Surveillance, Epidemiology, and End Results (SEER) Program (Used for Indicators H4 and H5) Brief description of the data set The Surveillance, Epidemiology, and End Results (SEER) program is an authoritative source of information on cancer incidence and mortality in the United States.

SEERFile Size: 83KB. The authors of this report used the Surveillance, Epidemiology, and End Results (SEER) Program to study prognostic factors in patients with HPC.

METHODS: The SEER database was analyzed for patients who were diagnosed with HPC tumors from to Patients were stratified into CNS and extra‐CNS groups. The SEER-Medicare data reflect the linkage of two large population-based sources of data that provide detailed information about Medicare beneficiaries with cancer.

SEER-Medicare Overview. We are now accepting requests for the Oncotype DX variable. The SEER-Medicare Data Files. SEER Program & Data. More About the Data Files. The SEER Program. The Surveillance, Epidemiology and End Results program has been a trusted source for high quality data since It currently monitors cancer incidence and survival in approximately 34% of the U.S.

population. SEER registries such as the CSS collect data on cancer incidence, treatment and survival. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute gathers cancer data from registries that span roughly 28% of the United States population.

In the present study, we used the SEER database to explore the epidemiology of DNT in this by: Surveillance, Epidemiology, and End Results (SEER) Program SEER Progress Report to the BSA November 7, Brenda K.

Edwards, Ph.D. Surveillance Research Program, NCI Sally Glaser, Ph.D. Northern California Cancer Center Dennis Deapen, Dr.P.H. University of Southern CaliforniaFile Size: 7MB. Glioma cases from the general population were identified from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program.

SEER cases were matched to ACTUR cases by age, sex, race, histology, and diagnosis year. All cases had histologically confirmed glioma diagnosed between January 1,and December The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) is a source of epidemiologic information on the incidence and survival rates of cancer.

A survival analysis for elucidation of survival and risk factors has yet to be performed in a population-based study. In the present study, we used the Surveillance, Epidemiology, and End Results Program (SEER) database to investigate and quantify the impact on survival of the extent of surgical resection and RT on a population-based scale.

MethodsCited by: 2. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI) is an important source of the longitudinal epidemiological study from multicenter population-based registries, which is updated annually and is available free of charge to the public.

Methods. With the Surveillance, Epidemiology, and End Results Program (SEER)–18 registry database, information from all patients diagnosed with SEGA from to was obtained (age, sex, race, marital status, tumor size, tumor location, occurrence of Cited by: 1.

Public-use data from the Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute were obtained about patients diagnosed with melanoma reported to SEER registries from through using SEER*Stat software, version (Silver Spring, MD).

35 Today, the SEER program represents approximately 26% of the United States, and is relatively Cited by: National Cancer Institute-Surveillance, Epidemiology and End Results Study.

In the National Cancer Institute-Surveillance, Epidemiology and End Results (NCI-SEER) lymphoma study, Dr. Cerhan's Lymphoma Epidemiology Lab is testing the hypothesis that genes with functional, common variant polymorphisms involved in immune function and regulation are associated with overall survival in non.

This study evaluated patients registered with the Surveillance, Epidemiology, and End Results (SEER) program who were diagnosed with a primary angiosarcoma of the head and neck region. The SEER program of the National Cancer Institute is a Cited by: 5. The act resulted in the establishment of the National Cancer Program under which the Surveillance, Epidemiology, and End Results (SEER) Program was developed.

A continuing project of the National Cancer Institute (NCI), the SEER Program collects cancer data on a routine basis from desig- nated population-based cancer registries in various areas.

Database Name: Surveillance, Epidemiology, and End Results (SEER) Description. Data Source. Population-based cancer registry covering 28% of the US population.

Data have been collected since The SEER program is overseen by the National Cancer Institute. Overview of data contents. The Surveillance Research Program (SRP) provides regularly updated surveillance and research data, statistical reports, and analytical tools on cancer.

Here are resources that SRP and its partners support. More popular reports/websites in each category are listed first. Interactive Tools. Can be tailored to information that is of greatest. Methods: We performed population-based cohort analyses using the Surveillance, Epidemiology, and End Results (SEER) database to identify patients with primary uveal melanoma from to Patients and potential prognosis indicators were extracted from SEER Author: Yufeng Xu, Lixia Lou, Yijie Wang, Qi Miao, Kai Jin, Menglu Chen, Juan Ye.

The data come from the Surveillance, Epidemiology and End Results (SEER) program of cancer registries that collect clinical, demographic and cause of death information for persons with cancer and the Medicare Health Outcomes Survey (MHOS) that provides information about the health-related quality of life (HRQOL) of Medicare Advantage.

The SEER Program serves three major thrusts of the NCI: cancer control, treatment, and epidemiology. The SEER Program was established in in response to the National Cancer Act ofwhich mandated that NCI collect, analyze, and disseminate all data useful in the prevention, diagnosis, and treatment of cancer (Public Law ).

The Silver Book® is an almanac of thousands of facts, statistics, graphs, and data from hundreds of agencies, organizations, and experts. It is a searchable database, produced and updated by the Alliance for Aging Research, that provides free and easy access to the latest information on the burden of chronic diseases that disproportionately.

An accessible, practical, pdf self-directed solution for CTRs to earn 20 Pdf credits per cycle. Username or e-mail: Forgot Username and/or Password? This browser is not supported by SEER*Educate.

Supported browsers: Firefox, Chrome, Internet Explorer Versions 9, 10, and IE Version 8 is NOT supported. Go to to update IE, go.THE SURVEILLANCE, EPIDEMIOLOGY, and End Results (SEER) Program of the National Cancer Institute (NCI) is an authoritative source of information on cancer incidence and survival in the United States.

SEER currently collects and publishes cancer. Dates of diagnosis ebook clinical information, for up to 10 cancer sites, from the Ebook file are included in each survey record that belongs to SEER-linked respondents.

A number of variables were calculated to describe the timing of the survey relative to cancer diagnosis including the patient's cancer status at the time of the survey (CASTAT).